New drug combination could reduce malaria infection risk in pregnant women living with HIV

Researchers have tested a new combination of medications that could thwart resistance to common malaria drugs, significantly reducing the infection risk in pregnant women living with HIV.

Related Keywords

Nairobi ,Nairobi Area ,Kenya ,Malawi ,Joachim Osur ,Hellen Barsosio ,Simon Kariuki ,Malawi University Of Science ,Liverpool School Of Tropical Medicine ,Kenya Medical Research Institute ,Malaria Policy Advisory Committee ,Amref International University ,Kamuzu University Of Health Sciences ,Saharan Africa ,Liverpool School ,Tropical Medicine ,Kamuzu University ,Health Sciences ,Malawi University ,Chief Research Officer ,Kenya Medical Research ,Policy Advisory Committee ,Shiv ,Malaria ,Ntibiotic ,Ihydroartemisinin ,Drugs ,Medical Research ,Medicine ,Iperaquine ,Pregnancy ,Research ,Technology ,